MKI67 and adrenal cortex carcinoma: A recent retrospective analysis has shown that adjuvant treatment with platinum-based chemotherapy is associated with prolonged RFS in ACC patients with a high risk of recurrence (ENSAT stages II-III and a median Ki-67 Index of 30%) (17).